일신바이오 / 2025.04.07 [정정] 사업보고서
1. 요약재무정보
(단위 : 원)
구분
제 31 기
제 30 기
제 29 기
2024년 12월말
2023년 12월말
2022년 12월말
[유동자산]
49,822,000,000
46,528,000,000
41,175,000,000
ㆍ매출채권및기타채권
1,826,000,000
2,694,000,000
4,322,000,000
ㆍ현금및현금성자산
1,730,000,000
3,150,000,000
5,712,000,000
ㆍ재고자산
10,648,000,000
10,319,000,000
9,082,000,000
ㆍ기타유동자산
35,618,000,000
30,365,000,000
22,059,000,000
[비유동자산]
14,118,000,000
14,090,000,000
17,276,000,000
ㆍ유형자산
9,993,000,000
10,378,000,000
10,487,000,000
ㆍ무형자산
1,709,000,000
1,747,000,000
1,788,000,000
ㆍ기타비유동자산
2,416,000,000
1,965,000,000
5,001,000,000
자산총계
63,940,000,000
60,618,000,000
58,451,000,000
[유동부채]
3,456,000,000
3,445,000,000
4,425,000,000
[비유동부채]
34,000,000
109,000,000
207,000,000
부채총계
3,490,000,000
3,554,000,000
4,632,000,000
[자본금]
4,422,000,000
4,422,000,000
4,422,000,000
[기타적립금]
2,090,000,000
2,090,000,000
4,437,000,000
[이익잉여금]
53,938,000,000
50,552,000,000
44,960,000,000
자본총계
60,450,000,000
57,064,000,000
53,819,000,000
구분
(2024.01.01 ~ 2024.12.31)
(2023.01.01 ~ 2023.12.31)
(2022.01.01 ~ 2022.12.31)
매출액
10,818,000,000
16,437,000,000
20,433,000,000
영업이익(손실)
2,262,000,000
6,214,000,000
5,140,000,000
당기순이익(손실)
3,812,000,000
6,232,000,000
3,815,000,000
당기총포괄이익(손실)
3,677,000,000
5,892,000,000
4,039,000,000
주당순이익(원)
91
148
89